| Brexpiprazole use in long-term care patients with major depressive disorder: Results from a retrospective analysis of long-term care data |
| Author(s): Greene M1, Seetasith A2, Hartry A3, Burudpakdee C2, 4 |
| Affiliations(s): 1Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA
2QuintilesIMS, Fairfax, VA, USA
3Lundbeck, LLC, Deerfield, IL, USA
4University of North Carolina at Charlotte, Charlotte, NC, USA
|
| Publication(s): ISPOR 22nd Annual International Meeting, Boston, 2017 |
| Document Type(s): Abstract |
| Countries: USA |
C: Y: |
Mental health 2017 |
|
L: A: |
English Retrospective database analysis |
|
|
| |
| |
| Adherence and treatment patterns of early adopters of brexpiprazole therapy with schizophrenia – Results from a retrospective analysis of longitudinal prescription data |
| Author(s): Greene M1, Seetasith A2, Hartry A3, Burudpakdee C2, 4 |
| Affiliations(s): 1Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA
2QuintilesIMS, Fairfax, VA, USA
3Lundbeck, LLC, Deerfield, IL, USA
4Universitiy of North Carolina at Charlotte, Charlotte, NC, USA
|
| Publication(s): ISPOR 22nd Annual International Meeting, Boston, 2017 |
| Document Type(s): Abstract |
| Countries: USA |
C: Y: |
Mental health 2017 |
|
L: A: |
English Retrospective database analysis |
|
|
| |
| |
| Adherence and treatment patterns in brexpiprazole therapy in long-term care patients with schizophrenia: Results from a retrospective analysis of long-term care data |
| Author(s): Greene M1, Seetasith A2, Hartry A3, Burudpakdee C2, 4 |
| Affiliations(s): 1Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA
2QuintilesIMS, Fairfax, VA, USA
3Lundbeck, LLC, Deerfield, IL, USA
4University of North Carolina at Charlotte, Charlotte, NC, USA
|
| Publication(s): ISPOR 22nd Annual International Meeting, Boston, 2017 |
| Document Type(s): Abstract |
| Countries: USA |
C: Y: |
Mental health 2017 |
|
L: A: |
English Retrospective database analysis |
|
|
| |
| |
| Brexpiprazole use in patients with major depressive disorder: Results from a retrospective analysis of longitudinal prescription data |
| Author(s): Greene M1, Seetasith A2, Hartry A3, Burudpakdee C2, 4 |
| Affiliations(s): 1Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA
2QuintilesIMS, Fairfax, VA, USA
3Lundbeck, LLC, Deerfield, IL, USA
4Universitiy of North Carolina at Charlotte, Charlotte, NC, USA
|
| Publication(s): ISPOR 22nd Annual International Meeting, Boston, 2017 |
| Document Type(s): Abstract |
| Countries: USA |
C: Y: |
Mental health 2017 |
|
L: A: |
English Retrospective database analysis |
|
|
| |
| |
| Italian neurologists’ perception on cognitive symptoms in major depressive disorder. |
| Author(s): Neri G1-2, Serrati C3, Zolo P4, Cataldo N5, Ripellino C5. |
| Affiliations(s): 1 Italian Society of Hospital Neurologists, Rome, Italy 2 Department of Neurology, San Filippo Neri Hospital, Rome, Italy 3 Department of Neurology, IRCCS San Martino Hospital—IST, Genoa, Italy 4 Ambulatorio Malattie Neurodegenerative, Istituto di Riabilitazione MDP, Agazzi, Italy 5 IMS Health Information Solutions Italy srl, Milan, Italy |
| Publication(s): Neurol Sci. DOI:10.1007/s10072-016-2601-2 |
| Document Type(s): Article |
| Countries: Italy |
| Click here for the abstract |
C: Y: |
Mental health, Neurological disorders 2016 |
|
L: A: |
English Survey research |
|
|
| |
| |
| TREATMENT INDICATIONS FOR ANTIDEPRESSANTS PRESCRIBED IN PRIMARY CARE IN FRANCE, 2006-2015 |
| Author(s): Schwalm MS, Miotti H, Hellard C, Nounit L, Trehony J, Jouaville SL |
| Affiliations(s): IMS HEALTH, Boulogne Billancourt, France |
| Publication(s): ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
| Document Type(s): Abstract |
| Countries: France |
C: Y: |
Clinical practice, Mental health 2016 |
|
L: A: |
English Clinical setting: Primary care, Retrospective database analysis |
|
|
| |
| |
| Three-monthly long-acting formulation of paliperidone palmitate is a dominant treatment option, cost saving while adding QALYs, compared to the one-monthly formulation in the treatment of schizophrenia in Belgium: a cost-utility study. |
| Author(s): De Moor R1, Malfait B2, Tedouri F3, De Vos C2, Van Gils C1 |
| Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium 2 Janssen-Cilag NV, Beerse, Belgium 3 Janssen Pharmaceutica NV, Beerse, Belgium |
| Publication(s): 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
| Document Type(s): Abstract |
| Countries: Belgium |
C: Y: |
Mental health 2016 |
|
L: A: |
English
|
|
|
| |
| |
| Three-monthly long-acting formulation of paliperidone palmitateis a dominant treatment option, cost saving while adding QALYs, compared to the one-monthly formulation in the treatment of schizophrenia in France. |
| Author(s): Arteaga Duarte C1, Colin X2, De Moor R1, Guillon P3, van Gils CW1
|
| Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium, 2 QuintilesIMS, La Défense, France, 3 Janssen-Cilag France, Issy-les-Moulineaux, Cedex, France |
| Publication(s): 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
| Document Type(s): Abstract |
| Countries: France |
C: Y: |
Mental health 2016 |
|
L: A: |
English Methodology |
|
|
| |
| |
| THREE-MONTHLY LONG-ACTING ANTIPSYCHOTIC THERAPY RESULTS IN A BETTER TREATMENT CONTINUITY COMPARED TO A ONE-MONTHLY OR BI-WEEKLY TREATMENT IN SCHIZOPHRENIA |
| Author(s):
Tedouri F1, Denee TR2, Malfait B3, Van Impe K2 |
| Affiliations(s): 1Janssen Pharmaceutica NV, Beerse, Belgium, 2Janssen-Cilag BV, Tilburg, The Netherlands, 3Janssen-Cilag NV, Beerse, Belgium |
| Publication(s): ISPOR 19th Annual European Congress
Vienna, Austria
October, 2016 |
| Document Type(s): Poster |
| Countries: Belgium, Netherlands |
C: Y: |
Mental health 2016 |
|
L: A: |
English Retrospective database analysis |
|
|
| |
| |
| The Medication Adherence in Schizophrenia Management by Using Second Generation Antipsychotics in Taiwan: A Population Study Based on Nhrid |
| Author(s): Chung C1,Tai TA2,Chou KP2 |
| Affiliations(s): 1-Mackay Medical College , New Taipei City , Taiwan
2-IMS Health Taiwan , Taipei , Taiwan |
| Publication(s): Value Health. 2016 nov; 19(7): A842 |
| Document Type(s): Abstract |
| Countries: Taiwan |
| Click here for the abstract |
C: Y: |
Mental health 2016 |
|
L: A: |
English Retrospective database analysis |
|
|
| |
| |
1 of 18
|